The Recall Desk
HighFDA (Devices)·Z-1444-2020·Announced 2020-03-11

Roche Recalls Elecsys CA 19-9 Reagent Due to Non-Reproducible Results

Roche Diagnostics is recalling 684 units of Elecsys CA 19-9 reagent because non-reproducible elevated results may affect clinical interpretation.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a medical device where non-reproducible results may affect clinical interpretation, representing a risk of harm where injury has not yet been reported.

Plain-English summary

Roche Diagnostics Operations, Inc. is recalling 684 units of Elecsys CA 19-9 reagent, Catalog Number 07027028190. This product is an immunoassay used for the monitoring and management of pancreatic cancer.

The recall was initiated after the firm received an increased number of complaints regarding non-reproducible elevated results, referred to as "high flyers," for one lot of the reagent. These results may affect clinical interpretation.

The affected product was distributed nationwide in the states of AL, AZ, CA, CO, FL, HI, IL, IN, KS, KY, MA, ME, MI, NC, NH, NJ, NY, TN, TX, WA, and WI. The source text does not specify instructions for consumers or healthcare providers on how to handle the recalled product.

The recalled product

Product
Elecsys CA 19-9, Cat. No. 07027028190 - Product Usage: the product is an immunoassay for monitoring and management of pancreatic cancer
Affected units
684

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • 50474
  • 525510
  • and 568976

Distribution

Distributed nationwide across the United States.

The notice also names 21 states specifically: